Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Clinical trial NCT01684163 · COMPLETED

Trial details

NCT number: NCT01684163
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2012-11-01
Primary completion: 2014-04-01
Enrollment: 369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.